Disease/Infection News

RSS

XBB.1.5 vaccine booster shows promise against new Omicron variants in latest study

A study posted to bioRxiv reveals that the monovalent XBB.1.5 vaccine booster significantly boosts neutralizing antibodies against new SARS-CoV-2 Omicron sub-variants. The research shows that both XBB.1.5 vaccination and infection elevate neutralizing titers, with the vaccine being particularly effective in infection-naïve individuals and those previously infected with Omicron.

29 Nov 2023

Lyme disease aftercare: new insights into persistent symptoms

Study explores the causes of persistent symptoms after Lyme borreliosis (LB) treatment, revealing that factors like social and physical functioning, psychological distress, and comorbidities are key determinants.

29 Nov 2023

Collaborative study focuses on understanding the strength of adhesion of COVID-19 variants

A recent groundbreaking study, published in Nature Nanotechnology, sheds new light on the coronavirus's behavior, particularly its ability to remain attached under various mechanical stresses and the implications for person-to-person transmission.

29 Nov 2023

Study reveals differences in SARS-CoV-2 entry mechanisms between humans and mink

Some viruses move between species. For example, SARS-CoV-2, the virus that causes COVID-19, can spill over from humans to mink, an agricultural species, and then spill back from mink to humans.

29 Nov 2023

Portable AI-driven COVID-19 test detects variants with high accuracy

A new AI-assisted molecular diagnostic platform capable of identifying variants of COVID-19 and other infectious diseases has been developed by scientists in the UK. The low cost, portable device could play a crucial role in preventing future pandemics due to its accuracy and versatility.

29 Nov 2023

COVID-19 in pregnancy tied to higher preterm birth risk; early vaccine adoption shows protective effect

The impact of maternal coronavirus disease 2019 (COVID-19) infection on infant health.

29 Nov 2023

Clinical trial reveals dapagliflozin's impact on heart failure and type 2 diabetes management

Researchers conducted a clinical trial on the effects of dapagliflozin on the urinary albumin-to-creatinine ratio (UACR) in patients with heart failure (HF) and type 2 diabetes mellitus (T2D).

29 Nov 2023

GOP presidential hopefuls use Trump’s covid record to court vaccine skeptics

Former President Donald Trump often seems proud to advertise his administration's record on speedily developing covid-19 vaccines.

29 Nov 2023

Chlorine-releasing agents in clinical settings fail to combat Clostridioides difficile spores

The current study highlights the resistance of C. difficile spores to chlorine-releasing agents.

29 Nov 2023

Exploring associations between BMI, cardiometabolic diseases, and cancer risk

Researchers evaluate the associations of body mass index, type 2 diabetes, and cardiovascular disease with cancer risk.

29 Nov 2023

COVID-19 in pregnancy raises preterm birth risk, vaccines offer crucial shield

Study reveals that pregnant women infected with COVID-19 had a higher risk of preterm delivery, with significant health and socioeconomic implications. However, early vaccination adopters showed protection from these effects, highlighting the critical role of vaccines in safeguarding future generations' health, especially in the U.S., where the study was conducted.

28 Nov 2023

Rare bacterial strain yields groundbreaking compounds to combat hepatitis B

Scientists have discovered new antiviral compounds from a rare bacterial strain, offering a novel approach to target hepatitis B virus. These compounds work by altering membrane permeability in infected cells, leading to the release of immature viral particles, a mechanism distinct from current HBV treatments.

28 Nov 2023

Researchers make great strides in combating pneumococcal pneumonia

The global impact of the coronavirus pandemic has ignited a renewed focus on emerging and re-emerging infectious diseases.

28 Nov 2023

HPV self-sampling kits via direct mail boost cervical cancer screening rates, study finds

Researchers examined the effectiveness of opt-in and direct-mail strategies for offering self-sampling kits of human papillomavirus (HPV) to populations based on cervical cancer screening history.

28 Nov 2023

Dr Farid Khan, PharmaKure CEO, to speak on Alzheimer's diagnosis and treatment at Biotech Outsourcing Strategies Manchester 2023

Talk to focus on the spinout journey from drug repurposing to clinical trials for diagnosing and treating Alzheimer’s Disease.

28 Nov 2023

Potential breakthrough in breast cancer: Five proteins identified as risk markers

Researchers used a Mendelian randomization approach to conduct a genetic association analysis of the levels of over 3,000 proteins to identify biomarkers for early breast cancer detection.

28 Nov 2023

Towards a world free of tuberculosis: The ADVANCE-TB COST Action

Tuberculosis (TB) is caused by Mycobacterium tuberculosis. For decades, it has been among the top 10 reasons of death globally, and the number one infectious killer.

28 Nov 2023

Study validates cancer risk reduction through lifestyle adherence

Researchers examined associations between adherence to cancer prevention recommendations by the World Cancer Research Fund (WCRF)/American Institute for Cancer Research (AICR) and cancer risk.

28 Nov 2023

Associations between socioeconomic status, clinical variables, and non-COVID-19 sepsis risk

The impact of socioeconomic status and clinical variables on sepsis incidence and mortality.

28 Nov 2023

Machine learning unlocks secrets of antimicrobial resistance, identifying over 900 key genes

Researchers employed advanced techniques like gene annotation, pangenomics, and machine learning to identify over 900 genes responsible for antimicrobial resistance in 12 bacterial species, outperforming traditional identification methods. This breakthrough approach offers new insights into the genetic basis of resistance, potentially guiding the development of more effective antibiotics

27 Nov 2023

Disease/Infection News

XBB.1.5 vaccine booster shows promise against new Omicron variants in latest study

Lyme disease aftercare: new insights into persistent symptoms

Collaborative study focuses on understanding the strength of adhesion of COVID-19 variants

Study reveals differences in SARS-CoV-2 entry mechanisms between humans and mink

Portable AI-driven COVID-19 test detects variants with high accuracy

COVID-19 in pregnancy tied to higher preterm birth risk; early vaccine adoption shows protective effect

Clinical trial reveals dapagliflozin's impact on heart failure and type 2 diabetes management

GOP presidential hopefuls use Trump’s covid record to court vaccine skeptics

Chlorine-releasing agents in clinical settings fail to combat Clostridioides difficile spores

Exploring associations between BMI, cardiometabolic diseases, and cancer risk

COVID-19 in pregnancy raises preterm birth risk, vaccines offer crucial shield

Rare bacterial strain yields groundbreaking compounds to combat hepatitis B

Researchers make great strides in combating pneumococcal pneumonia

HPV self-sampling kits via direct mail boost cervical cancer screening rates, study finds

Dr Farid Khan, PharmaKure CEO, to speak on Alzheimer's diagnosis and treatment at Biotech Outsourcing Strategies Manchester 2023

Potential breakthrough in breast cancer: Five proteins identified as risk markers

Towards a world free of tuberculosis: The ADVANCE-TB COST Action

Study validates cancer risk reduction through lifestyle adherence

Associations between socioeconomic status, clinical variables, and non-COVID-19 sepsis risk

Machine learning unlocks secrets of antimicrobial resistance, identifying over 900 key genes

Real-time Raman monitoring for pharmaceutical hot melt extrusion

Synthetic Psychedelics: A Growing Public Health Concern

How the Vutara VXL simplifies single-molecule imaging

Latest News